Chapter 1: Discoveries in Treatment

What if I were to tell you that a potential cure for Covid-19 has emerged? Recent developments from Israel suggest that researchers have discovered two medications that may effectively combat the virus.

In Tel Aviv, Professor Nadir Arber has pioneered a drug named EXO-CD24, which recently achieved successful results in its initial clinical trial.

According to the Telegraph, this treatment was administered to thirty individuals suffering from moderate to severe Covid symptoms. Remarkably, twenty-nine patients recovered and were discharged within five days, while one required additional time for recovery.

Originally intended for ovarian cancer treatment, this medication is inhaled daily over a five-day period. The mechanism of action is as follows:

“A protein called CD24 is conveyed to the lungs via exosomes in the formulation, assisting in rebalancing the immune system and preventing excessive reactions to the virus.”

Despite these encouraging early results, a comprehensive journey toward licensing and thorough testing remains ahead. Professor Arber emphasized:

“Even if vaccines are effective and new mutations are avoided, the coronavirus will persist. Therefore, we developed this specialized medication. It has taken approximately six months from concept to the initiation of human trials.”

The subsequent phase of clinical trials will further investigate the drug's efficacy and any potential side effects.

This video discusses how an Israeli lab has identified existing drugs that may effectively treat Covid-19.

The second promising drug is Allocetra, developed by Dr. Dror Mevorach at Enlivex Therapeutics. This immunotherapy addresses the severe immune responses experienced by some patients, which can lead to organ failure or death.

As reported by the Telegraph, Allocetra has demonstrated the ability to significantly improve Covid symptoms within a mere two hours. It has completed phases one and two of clinical trials, involving twenty severely ill patients, with nineteen achieving full recovery and being released from the hospital after five days.

Yair Tayeb, one of the patients, recounted his experience to the Times of Israel:

“I struggled to breathe and could barely speak. I was in critical condition. After receiving the drug, within two hours, I sensed a change in my body. My cough subsided, my breathing improved, and I felt revitalized. I was overwhelmed with joy.”

Currently, Allocetra is advancing into its third trial phase.

Professor Stephen Evans from the London School of Hygiene & Tropical Medicine remarked, “This drug may show promise for treating severely ill Covid-19 patients.” However, he advised caution, noting that the results stem from an observational study rather than a randomized controlled trial.

These experimental therapies signify a significant advancement in our efforts against the pandemic. If proven effective and safe, they could lead us closer to overcoming the virus and embarking on a collective recovery. I remain hopeful for their success.

Chapter 2: Hope for the Future

In this video, Israeli scientists share their findings on a potential cancer cure, showcasing the innovative research being done in the medical field.